Medical device and drug recalls, whether voluntary or mandated by the FDA, ensure patient safety. Here are six that have been reported to the FDA since the beginning of September:
- Jacobus Pharmaceutical Company recalled three lots of Ruzurgi, a drug used to treat Lambert Eaton syndrome, after finding they were contaminated with yeast, mold and aerobic bacteria.
- The FDA has recalled all ultrasound gels and lotions made by Eco-Med Pharmaceuticals because of the risk of bacterial contamination with Burkholderia cepacia complex. The gels and lotions have been associated with at least 66 infections, including 60 bloodstream infections. Eco-Med has shut down all operations and is no longer manufacturing or distributing any products.
- Azurity Pharmaceuticals recalled one lot of Firvanq after finding some products in the lot contain a First Omeprazole diluent instead of the Firvanq diluent.
- ICU medical recalled one lot of aminosyn after finding it was contaminated with fibers, hair and other particles.
- Magellan Diagnostics expanded its recall of blood lead tests, which was initiated in May after the company identified an ongoing issue with the controls used in the tests.
- Teligent Pharma recalled one lot of its lidocaine topical solution after finding it was super potent.